Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Clinical Neurophysiology Practice
|
March 24, 2025
Multimodal tele-epileptology: Challenges on the way to interoperable medical data
Sigrid Mues, Arndt Ebert, Marc Kämmerer, et al.
BMJ Neurology Open
|
March 6, 2026
Safety, tolerability and biomarker results of bepranemab in participants with progressive supranuclear palsy: a randomised, multicentre, double-blind, placebo-controlled, phase 1b trial
Günter Höglinger, Wim Vandenberghe, Dirk Woitalla, et al.
Neurotoxicology
|
August 30, 2017
Association of exposure to manganese and iron with relaxation rates R1 and R2*- magnetic resonance imaging results from the WELDOX II study
Beate Pesch, Ulrike Dydak, Anne Lotz, et al.
Neurotoxicology
|
December 10, 2020
Association of exposure to manganese and fine motor skills in welders - Results from the WELDOX II study
Anne Lotz, Beate Pesch, Swaantje Casjens, et al.
Neurotoxicology
|
August 15, 2017
Association of exposure to manganese and iron with striatal and thalamic GABA and other neurometabolites - Neuroimaging results from the WELDOX II study
Swaantje Casjens, Urike Dydak, Shalmali Dharmadhikari, et al.
Human Mutation
|
September 15, 2004
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7)
Robert Hering, Karsten M Strauss, Xiao Tao, et al.
Cells
|
February 1, 2019
Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease
Beate Pesch, Swaantje Casjens, Dirk Woitalla, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 17, 2005
Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients
Daniela Berg, Marc Niwar, Sylvia Maass, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 1, 2024
Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries
Christopher Kruse, Anna Lipinski, Malte Verheyen, et al.
Science Translational Medicine
|
September 10, 2020
A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson's disease
Ibrahim Boussaad, Carolin D Obermaier, Zoé Hanss, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Clinical Neurophysiology Practice
|
March 24, 2025
Multimodal tele-epileptology: Challenges on the way to interoperable medical data
Sigrid Mues, Arndt Ebert, Marc Kämmerer, et al.
BMJ Neurology Open
|
March 6, 2026
Safety, tolerability and biomarker results of bepranemab in participants with progressive supranuclear palsy: a randomised, multicentre, double-blind, placebo-controlled, phase 1b trial
Günter Höglinger, Wim Vandenberghe, Dirk Woitalla, et al.
Neurotoxicology
|
August 30, 2017
Association of exposure to manganese and iron with relaxation rates R1 and R2*- magnetic resonance imaging results from the WELDOX II study
Beate Pesch, Ulrike Dydak, Anne Lotz, et al.
Neurotoxicology
|
December 10, 2020
Association of exposure to manganese and fine motor skills in welders - Results from the WELDOX II study
Anne Lotz, Beate Pesch, Swaantje Casjens, et al.
Neurotoxicology
|
August 15, 2017
Association of exposure to manganese and iron with striatal and thalamic GABA and other neurometabolites - Neuroimaging results from the WELDOX II study
Swaantje Casjens, Urike Dydak, Shalmali Dharmadhikari, et al.
Human Mutation
|
September 15, 2004
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7)
Robert Hering, Karsten M Strauss, Xiao Tao, et al.
Cells
|
February 1, 2019
Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease
Beate Pesch, Swaantje Casjens, Dirk Woitalla, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 17, 2005
Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients
Daniela Berg, Marc Niwar, Sylvia Maass, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 1, 2024
Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries
Christopher Kruse, Anna Lipinski, Malte Verheyen, et al.
Science Translational Medicine
|
September 10, 2020
A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson's disease
Ibrahim Boussaad, Carolin D Obermaier, Zoé Hanss, et al.
Page
of 7